Publications - 'O'

Publications 151 - 175 de 1113
| % | ( | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | < | ? | A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | [ | ` | {
Titre DOI
Oesophageal cancer: exploring controversies overview of experts' opinions of Austria, Germany, France, Netherlands and Switzerland
P.Martin Putora; L. Bedenne; W. Budach; W. Eisterer; A. Van Der Gaast; R. Jaeger; J.B. Van Lanschot; C. Mariette; A. Schnider; M. Stahl; T. Ruhstaller
2015
10.1186/s13014-015-0418-4
Oesophagus polyps: Giant fibrovascular polyp of the oesophagus disappears!
C. Molimard; L. Vuitton; Z. Boulahdour; S. Koch; L. Chaigneau; P. Mathieu; S. Valmary-Degano
2019
10.1016/j.annpat.2019.02.011
Oestrus ovis external ophtalmomyiasis: a case report in Burgundy France
L. Basmaciyan; P.H. Gabrielle; S. Valot; M. Sautour; J.C. Buisson; C. Creuzot-Garcher; F. Dalle
2018
10.1186/s12886-018-1003-z
Off-label drugs in childhood psoriasis
E. Mahe; F. Corgibet; F. Maccari; S. Hadj-Rabia; C. Phan; M. Ruer-Mulard; F. Boralevi; S. Barbarot; A.C. Bursztejn; M. Lahfa; M. Severino-Freire; F. Aubin; H. Barthelemy; A. de la Breteque; A. Beauchet; G.E.M. Resopso
2020
10.1016/j.annder.2020.01.021
Off-label thrombolysis: A complex decision requiring a collegial agreement
B. Bouamra; M. de Bustos; F. Vuillier; P. Montiel; L. Bonnet; T. Moulin
2015
Off-Label Use of Biological Therapies in Relapsing and/or Refractory Eosinophilic Granulomatosis with Polyangiitis (Churg-Strauss)
L. Denis; M. Samson; F. Maurier; C. Khouatra; V. Germain; X. Delbrel; P. Bonniaud; A. Deroux; N. Girszyn; C. de Moreuil; D. Chauveau; A. Gondouin; S. Dominique; G. Le Guenno; L. Bouillet; B. Bonnotte; J.E. Kahn; B. Bienvenu; B. Godeau; C. Le Jeunne; X. Puechal; B. Terrier; L.Guillevin Vasculitis
2017
Off-Label Use of Biological Therapies in Relapsing and/or Refractory Eosinophilic Granulomatosis with Polyangiitis (Churg-Strauss)
L. Denis; M. Samson; F. Maurier; C. Khouatra; V. Germain; X. Delbrel; P. Bonniaud; A. Deroux; N. Girszyn; C. de Moreuil; D. Chauveau; A. Gondouin; S. Dominique; G. Le Guenno; L. Bouillet; B. Bonnotte; J.E. Kahn; B. Bienvenu; B. Godeau; C. Le Jeunne; X. Puechal; B. Terrier; L.Guillevin Vasculitis
2017
Off-label use of biologics for the treatment of refractory and/or relapsing granulomatosis with polyangiitis
C. Mettler; C.A. Durel; P. Guilpain; B. Bonnotte; F. Cohen-Aubart; M. Hamidou; J.C. Lega; V. Le Guern; F. Lifermann; V. Poindron; G. Pugnet; A. Servettaz; X. Puechal; L. Guillevin; B. Terrier; F.Vasculitis Grp
2022
10.1016/j.ejim.2021.10.028
Off-Label Use of Biotherapies to Treat Relapsing And/or Refractory Eosinophilic Granulomatosis with Polyangiitis (Churg-Strauss)
A. Canzian; N. Venhoff; S. Sartorelli; A.M. Ruppert; M. Groh; C. Taille; V. Rieu; P. Smets; F. Maurier; N. Girszyn; M. Samson; C. de Moreuil; G. Pugnet; X. Delbrel; J.E. Kahn; G. Emmi; L. Guillevin; L. Dagna; J. Thiel; A. Vaglio; B. Terrier; X.Puechal Fr Vasculitis
2019
Off-Label Use of Biotherapies to Treat Relapsing And/or Refractory Eosinophilic Granulomatosis with Polyangiitis (Churg-Strauss)
A. Canzian; N. Venhoff; S. Sartorelli; A.M. Ruppert; M. Groh; C. Taille; V. Rieu; P. Smets; F. Maurier; N. Girszyn; M. Samson; C. de Moreuil; G. Pugnet; X. Delbrel; J.E. Kahn; G. Emmi; L. Guillevin; L. Dagna; J. Thiel; A. Vaglio; B. Terrier; X.Puechal Fr Vasculitis
2019
Off-label use of targeted therapies in osteosarcomas: data from the French registry OUTC'S (Observatoire de l'Utilisation des Therapies Ciblees dans les Sarcomes)
M. Penel-Page; I. Ray-Coquard; J. Larcade; M. Girodet; L. Bouclier; M. Rogasik; N. Corradini; N. Entz-Werle; L. Brugieres; J. Domont; C. Lervat; S. Piperno-Neumann; H. Pacquement; J.O. Bay; J.C. Gentet; A. Thyss; L. Chaigneau; B. Narciso; H. Cornille; J.Y. Blay; P. Marec-Berard
2015
10.1186/s12885-015-1894-5
Off-line Text-independent Writer Identification Using Local Convex Micro-Structure Patterns
A. Chahi; Y.El Merabet; Y. Ruichek; R. Touahni
2019
10.1145/3314074.3314080
Official Texts on Physical Education, Sport, and Adolescence from 1925 to the Present Day
M. Le Paven; E. Lefevre
2015
10.3917/sta.108.0037
Offsetting Self-Phase Modulation in Optical Fibre by Sinusoidally Time-Varying Phase
S. Boscolo; F. Audo; M. Sumetsky; C. Finot
2018
Offsetting Self-Phase Modulation in Optical Fibre by Sinusoidally Time-Varying Phase
S. Boscolo; F. Audo; M. Sumetsky; C. Finot
2018
Offspring Microbiomes Differ Across Breeding Sites in a Panmictic Species
M.Alan Frank Gillingham; A. Bechet; F. Cezilly; K. Wilhelm; M. Rendon-Martos; F. Borghesi; S. Nissardi; N. Baccetti; H. Azafzaf; S. Menke; Y. Kayser; S. Sommer
2019
10.3389/fmicb.2019.00035
OFIP/KIAA0753 forms a complex with OFD1 and FOR20 at pericentriolar satellites and centrosomes and is mutated in one individual with oral-facial-digital syndrome
V. Chevrier; A.L. Bruel; T.J.P. Van Dam; B. Franco; M.Lo Scalzo; F. Lembo; S. Audebert; E. Baudelet; D. Isnardon; A. Bole; J.P. Borg; P. Kuentz; J. Thevenon; L. Burglen; L. Faivre; J.B. Riviere; M.A. Huynen; D. Birnbaum; O. Rosnet; C. Thauvin-Robinet
2016
10.1093/hmg/ddv488
Okur-Chung neurodevelopmental syndrome: Eight additional cases with implications on phenotype and genotype expansion
A.T.G. Chiu; S.L.C. Pei; C.C.Y. Mak; G.K.C. Leung; M.H.C. Yu; S.L. Lee; M. Vreeburg; R. Pfundt; I. van der Burgt; T. Kleefstra; T.M.T. Frederic; S. Nambot; L. Faivre; A.L. Bruel; M. Rossi; B. Isidor; S. Kury; B. Cogne; T. Besnard; M. Willems; M.R.F. Reijnders; B.H.Y. Chung
2018
10.1111/cge.13196
Olaparib for Metastatic Castration-Resistant Prostate Cancer
J. de Bono; J. Mateo; K. Fizazi; F. Saad; N. Shore; S. Sandhu; K.N. Chi; O. Sartor; N. Agarwal; D. Olmos; A. Thiery-Vuillemin; P. Twardowski; N. Mehra; C. Goessl; J. Kang; J. Burgents; W. Wu; A. Kohlmann; C.A. Adelman; M. Hussain
2020
10.1056/NEJMoa1911440
Old Dog, New Tricks: Innocent, Five-coordinate Cyanocobalt Corroles
R. Osterloh; N. Desbois; V. Quesneau; S. Brandes; P. Fleurat-Lessard; Y. Fang; V. Blondeau-Patissier; R. Paolesse; C.P. Gros; K.M. Kadish
2020
10.1021/acs.inorgchem.0c01037
Older adults with SARS-CoV-2 infection: Utility of the clinical frailty scale to predict mortality
M. Gilis; N. Chagrot; S. Koeberle; T. Tannou; A.S. Brunel; C. Chirouze; K. Bouiller
Submitted
10.1002/jmv.26766, Early Access Date = {JAN 2021
Older adults with SARS-CoV-2 infection: Utility of the clinical frailty scale to predict mortality
M. Gilis; N. Chagrot; S. Koeberle; T. Tannou; A.S. Brunel; C. Chirouze; K. Bouiller
2021
10.1002/jmv.26766
Older volunteers in France: recognising their social utility in a less and less corporatist welfare state
M. Poussou-Plesse; E. Mascova; M. Petit
2014
Oleanane-type glycosides from Pittosporum tenuifolium ``variegatum'' and P. tenuifolium ``gold star''
M.Rengifo Carrillo; A.C. Mitaine-Offer; T. Miyamoto; C. Tanaka; L. Pouysegu; S. Quideau; L.B. Rojas; C.Rosquete Porcar; M.A. Lacaille-Dubois
2017
10.1016/j.phytochem.2017.04.013
Oleanane-type glycosides from the roots of Weigela florida ``rumba'' and evaluation of their antibody recognition
A.S. Champy-Tixier; A.C. Mitaine-Offer; F.Real Fernandez; T. Miyamoto; C. Tanaka; A.M. Papini; M.A. Lacaille-Dubois
2018
10.1016/j.fitote.2018.04.017

Pages